Dunlop A. Sinclair

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(9%)9%(3%)(19%)0%
Sale Success Rate0 of 52 of 50 of 50 of 50 of 5

Apellis Pharmaceuticals, Inc.

Other » Other

Director:

Holdings: 252.13K shares

Sentiment

Insider Trading Sentiment: Reduce

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--